![Martin Phillips](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin Phillips
Amministratore Delegato presso Opsidio LLC
Profilo
Martin Phillips is currently the Chief Executive Officer & Director at Opsidio LLC since 2017.
Prior to this, he worked as the Senior Medical Director at Aventis Behring from 1997 to 2004.
He also held positions as Director at Context Therapeutics LLC, Chief Medical Officer & SVP-Clinical Development at Morphotek, Inc., and Chief Medical Officer at Millendo Therapeutics US, Inc. Additionally, he worked as an Associate Professor-Medicine at The University of Texas at Austin and as an Assistant Professor-Medicine at Baylor College of Medicine.
Dr. Phillips holds a doctorate degree from Wayne State University (Michigan) and an undergraduate degree from the University of Michigan.
Posizioni attive di Martin Phillips
Società | Posizione | Inizio |
---|---|---|
Opsidio LLC
![]() Opsidio LLC Pharmaceuticals: MajorHealth Technology Opsidio LLC engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases. The company is headquartered in Bryn Mawr, PA. | Amministratore Delegato | 03/10/2017 |
Precedenti posizioni note di Martin Phillips
Società | Posizione | Fine |
---|---|---|
Aventis Behring | Direttore Tecnico/Scientifico/R&S | - |
Context Therapeutics LLC
![]() Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Direttore/Membro del Consiglio | - |
Millendo Therapeutics US, Inc.
![]() Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | Direttore Tecnico/Scientifico/R&S | - |
The University of Texas at Austin | Corporate Officer/Principal | - |
Baylor College of Medicine | Corporate Officer/Principal | - |
Formazione di Martin Phillips
Wayne State University (Michigan) | Doctorate Degree |
University of Michigan | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
Morphotek, Inc.
![]() Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Commercial Services |
Millendo Therapeutics US, Inc.
![]() Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | Health Technology |
Aventis Behring | Health Technology |
Opsidio LLC
![]() Opsidio LLC Pharmaceuticals: MajorHealth Technology Opsidio LLC engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases. The company is headquartered in Bryn Mawr, PA. | Health Technology |
Context Therapeutics LLC
![]() Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Health Technology |
- Borsa valori
- Insiders
- Martin Phillips